FPR1 and neoplasm: As tumor evolves, the activation of ANXA1-FPR1/2-STAT3 axis in the microglia suppresses anti-tumor immunity through up-regulation of pro-tumorigenic factors, and down-regulation of anti-tumorigenic factors.